All Updates

MONTPELIER – May 23, 2018 – Vermont has made great headway in tackling the problem of tobacco, but it is far from solved. Tobacco is still the number one cause of preventable death nationwide. As the budget debate simmers in Montpelier this week, the Coalition for a Tobacco Free Vermont

The American Cancer Society Cancer Action Network (ACS CAN), Friends of Cancer Research (FOCR), and the National Organization for Rare Disorders (NORD) along with more than 100 advocacy groups representing millions of patients submitted a letter to Members of the House of Representatives strongly opposing the Senate Right-to-Try Act (S. 204).

WASHINGTON, D.C. – Today the U.S. House of Representatives unanimously passed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act, sending the bill to the president’s desk for enactment. The STAR Act, which was co-sponsored by 370 House members and also passed the Senate unanimously earlier this year, represents

Washington, D.C. – May 22, 2018 – The House of Representatives passed legislation today that, if signed into law, will create a process for accessing experimental drugs without including proper patient protections. The Senate Right-to-Try legislation (S. 204) was strongly opposed by the American Cancer Society Cancer Action Network (ACS

SPRINGDALE, Ark. – Local American Cancer Society Cancer Action Network volunteer Abbie Luzius joined more than 100 other cancer patients, survivors, caregivers, physicians and researchers in Washington, D.C., this week to urge lawmakers to make fighting cancer a top national priority. These advocates united for the 19 th annual One

American Cancer Society Cancer Action Network volunteer Courtney Hurtig, of Overland Park, joined more than 100 other cancer patients, survivors, caregivers, physicians and researchers in Washington, D.C., this week to urge lawmakers to make fighting cancer a top national priority. These advocates united as part of the 19 th annual One Voice Against Cancer lobby day to request cancer research funding at the National Cancer Institute and National Institutes of Health.